Aliya A Khan

Summary

Publications

  1. pmc Primary hyperparathyroidism: pathophysiology and impact on bone
    A Khan
    McMaster University, Hamilton, Ont
    CMAJ 163:184-7. 2000
  2. doi request reprint Bisphosphonate associated osteonecrosis of the jaw
    Aliya A Khan
    Divisions of Endocrinology and Geriatrics, McMaster University, Oakville, ON L6J 1X8, Canada
    J Rheumatol 36:478-90. 2009
  3. ncbi request reprint Bone mineral density assessment in premenopausal women
    Aliya Khan
    McMaster University, Hamilton, Ontario, Canada
    Womens Health (Lond Engl) 2:639-45. 2006
  4. pmc Premenopausal women and low bone density
    Aliya Khan
    Division of Endocrinology, McMaster University, Hamilton, Ont
    Can Fam Physician 52:743-7. 2006
  5. ncbi request reprint Standards for performing DXA in individuals with secondary causes of osteoporosis
    Aliya A Khan
    Division of Endocrinology, McMaster University, Hamilton, Ontario, Canada, and Hanover General Hospital, PA, USA
    J Clin Densitom 9:47-57. 2006
  6. ncbi request reprint Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo-controlled trial
    Aliya A Khan
    McMaster University, 331 209 Sheddon Avenue, Oakville, Ontario, Canada L6J 1X8
    J Clin Endocrinol Metab 89:3319-25. 2004
  7. ncbi request reprint Bone densitometry in premenopausal women: synthesis and review
    Aliya A Khan
    Department of Medicine, Divisions of Endocrinology and Geriatrics, McMaster University, Hamilton, Ontario, Canada
    J Clin Densitom 7:85-92. 2004
  8. ncbi request reprint Standards and guidelines for performing central dual-energy x-ray absorptiometry in premenopausal women, men, and children
    Aliya A Khan
    Divisions of Endocrinology and Geriatrics, McMaster University, Hamilton, ON, Canada
    J Clin Densitom 7:51-64. 2004
  9. pmc Advances in osteoporosis therapy. 2003 update of practical guidelines
    Aliya Khan
    McMaster University, Hamilton, Ont
    Can Fam Physician 49:441-7. 2003
  10. pmc The 2002 Canadian bone densitometry recommendations: take-home messages
    Aliya A Khan
    Division of Geriatrics, McMaster University, Hamilton, ON
    CMAJ 167:1141-5. 2002

Detail Information

Publications20

  1. pmc Primary hyperparathyroidism: pathophysiology and impact on bone
    A Khan
    McMaster University, Hamilton, Ont
    CMAJ 163:184-7. 2000
    ..Thus, a new class of therapeutics may include the calcimimetic agents. Bisphosphonates are also currently being evaluated with regard to their impact on fracture prevention and their beneficial effects on bone mineral density...
  2. doi request reprint Bisphosphonate associated osteonecrosis of the jaw
    Aliya A Khan
    Divisions of Endocrinology and Geriatrics, McMaster University, Oakville, ON L6J 1X8, Canada
    J Rheumatol 36:478-90. 2009
    ..Prevention and treatment strategies are currently based on expert opinion and focus on maintaining good oral hygiene and conservative surgical intervention...
  3. ncbi request reprint Bone mineral density assessment in premenopausal women
    Aliya Khan
    McMaster University, Hamilton, Ontario, Canada
    Womens Health (Lond Engl) 2:639-45. 2006
    ..Bone mineral density testing should only be performed in premenopausal women in the presence of approved indications...
  4. pmc Premenopausal women and low bone density
    Aliya Khan
    Division of Endocrinology, McMaster University, Hamilton, Ont
    Can Fam Physician 52:743-7. 2006
    ..Diagnosis and management recommendations were based on evidence from randomized controlled trials and expert consensus...
  5. ncbi request reprint Standards for performing DXA in individuals with secondary causes of osteoporosis
    Aliya A Khan
    Division of Endocrinology, McMaster University, Hamilton, Ontario, Canada, and Hanover General Hospital, PA, USA
    J Clin Densitom 9:47-57. 2006
    ..Dual-energy X-ray absorptiometry is a valuable tool in assessing skeletal health in individuals with secondary causes of osteoporosis...
  6. ncbi request reprint Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo-controlled trial
    Aliya A Khan
    McMaster University, 331 209 Sheddon Avenue, Oakville, Ontario, Canada L6J 1X8
    J Clin Endocrinol Metab 89:3319-25. 2004
    ..Significant reductions in bone turnover occur with stable serum calcium and PTH levels. Alendronate may be a useful alternative to parathyroidectomy in asymptomatic PHPT among those with low BMD...
  7. ncbi request reprint Bone densitometry in premenopausal women: synthesis and review
    Aliya A Khan
    Department of Medicine, Divisions of Endocrinology and Geriatrics, McMaster University, Hamilton, Ontario, Canada
    J Clin Densitom 7:85-92. 2004
    ..As new treatment options are evaluated and become available, biomarker assessment may be of value in identifying women at risk of fracture...
  8. ncbi request reprint Standards and guidelines for performing central dual-energy x-ray absorptiometry in premenopausal women, men, and children
    Aliya A Khan
    Divisions of Endocrinology and Geriatrics, McMaster University, Hamilton, ON, Canada
    J Clin Densitom 7:51-64. 2004
    ..Previously, this group addressed the performance of densitometry in postmenopausal women. This report addresses the use of densitometry in men, premenopausal women, and children with a focus on dual-energy X-ray absorptiometry...
  9. pmc Advances in osteoporosis therapy. 2003 update of practical guidelines
    Aliya Khan
    McMaster University, Hamilton, Ont
    Can Fam Physician 49:441-7. 2003
    ..To review evidence for current therapies for postmenopausal osteoporosis and to establish practical guidelines for management of osteoporosis by family physicians...
  10. pmc The 2002 Canadian bone densitometry recommendations: take-home messages
    Aliya A Khan
    Division of Geriatrics, McMaster University, Hamilton, ON
    CMAJ 167:1141-5. 2002
  11. pmc Bisphosphonate-associated osteonecrosis of the jaw
    Aliya Khan
    Clinical Medicine at McMaster University in Hamilton, Ont
    Can Fam Physician 54:1019-21. 2008
  12. ncbi request reprint Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw
    Aliya A Khan
    Divisions of Endocrinology and Geriatrics, McMaster University, Hamilton, Ontario, Canada
    J Rheumatol 35:1391-7. 2008
    ..These guidelines were developed for medical and dental practitioners as well as for oral pathologists and related specialists...
  13. ncbi request reprint Standards and guidelines for technologists performing central dual-energy X-ray absorptiometry
    Aliya A Khan
    Division of Endocrinology, McMaster University, Hamilton, Ontario, Canada
    J Clin Densitom 10:189-95. 2007
  14. pmc Management of osteoporosis in men: an update and case example
    Aliya A Khan
    Division of Endocrinology and Geriatrics, Department of Medicine, McMaster University, Hamilton, Ont
    CMAJ 176:345-8. 2007
    ..The current paper supplements that guideline and provides a review and synthesis of the current literature on the diagnosis and management of osteoporosis in men...
  15. doi request reprint Bisphosphonate-associated osteonecrosis of the jaw in Ontario: a survey of oral and maxillofacial surgeons
    Aliya A Khan
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    J Rheumatol 38:1396-402. 2011
    ..The frequency of the condition in patients with osteoporosis appears to be low. We evaluated the frequency of BP-associated ONJ in Ontario in the cancer population and in those receiving BP for osteoporosis and metabolic bone disease...
  16. doi request reprint Alendronate therapy in men with primary hyperparathyroidism
    Aliya A Khan
    Department of Medicine, Divisions of Endocrinology and Geriatrics, McMaster University, Hamilton, Ontario, Canada
    Endocr Pract 15:705-13. 2009
    ..To determine the skeletal effects of alendronate therapy in men with primary hyperparathyroidism (PHPT) in comparison with those in postmenopausal women...
  17. doi request reprint Official Positions for FRAX® clinical regarding international differences from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®
    Jane A Cauley
    Department of Epidemiology, University of Pittsburgh, PA, USA
    J Clin Densitom 14:240-62. 2011
    ..The statements approved by the panel of experts are discussed in the current paper...
  18. doi request reprint Medical management of primary hyperparathyroidism
    Aliya A Khan
    McMaster University, Hamilton, Ontario, Canada
    J Clin Densitom 16:60-3. 2013
    ..There are currently no fracture data for the medical options available, and prospective randomized controlled trials are required to confirm the effects of medical therapy on fracture risk reduction in those with asymptomatic PHPT...
  19. doi request reprint Hypoparathyroidism
    Hafsah Al-Azem
    McMaster University, 1101 75 Bold St, Hamilton, Ontario L8P 1T7, Canada
    Best Pract Res Clin Endocrinol Metab 26:517-22. 2012
    ....
  20. doi request reprint FRAX® International Task Force of the 2010 Joint International Society for Clinical Densitometry & International Osteoporosis Foundation Position Development Conference
    Jane A Cauley
    Department of Epidemiology, University of Pittsburgh, PA, USA
    J Clin Densitom 14:237-9. 2011
    ..This synthesis was presented to the expert panel and constitutes the data on which the subsequent Official Positions are predicated. A summary of the International Task Force composition and charge is presented here...